263 related articles for article (PubMed ID: 17135314)
1. The human TRIM5alpha restriction factor mediates accelerated uncoating of the N-tropic murine leukemia virus capsid.
Perron MJ; Stremlau M; Lee M; Javanbakht H; Song B; Sodroski J
J Virol; 2007 Mar; 81(5):2138-48. PubMed ID: 17135314
[TBL] [Abstract][Full Text] [Related]
2. Two surface-exposed elements of the B30.2/SPRY domain as potency determinants of N-tropic murine leukemia virus restriction by human TRIM5alpha.
Perron MJ; Stremlau M; Sodroski J
J Virol; 2006 Jun; 80(11):5631-6. PubMed ID: 16699044
[TBL] [Abstract][Full Text] [Related]
3. TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells.
Perron MJ; Stremlau M; Song B; Ulm W; Mulligan RC; Sodroski J
Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11827-32. PubMed ID: 15280539
[TBL] [Abstract][Full Text] [Related]
4. A human TRIM5alpha B30.2/SPRY domain mutant gains the ability to restrict and prematurely uncoat B-tropic murine leukemia virus.
Diaz-Griffero F; Perron M; McGee-Estrada K; Hanna R; Maillard PV; Trono D; Sodroski J
Virology; 2008 Sep; 378(2):233-42. PubMed ID: 18586294
[TBL] [Abstract][Full Text] [Related]
5. Complex determinants within the Moloney murine leukemia virus capsid modulate susceptibility of the virus to Fv1 and Ref1-mediated restriction.
Ulm JW; Perron M; Sodroski J; C Mulligan R
Virology; 2007 Jul; 363(2):245-55. PubMed ID: 17343889
[TBL] [Abstract][Full Text] [Related]
6. A novel envelope mediated post entry restriction of murine leukaemia virus in human cells is Ref1/TRIM5α independent.
Oliveira NM; Trikha R; McKnight Á
Retrovirology; 2010 Oct; 7():81. PubMed ID: 20929586
[TBL] [Abstract][Full Text] [Related]
7. Novel escape mutants suggest an extensive TRIM5α binding site spanning the entire outer surface of the murine leukemia virus capsid protein.
Ohkura S; Goldstone DC; Yap MW; Holden-Dye K; Taylor IA; Stoye JP
PLoS Pathog; 2011 Mar; 7(3):e1002011. PubMed ID: 21483490
[TBL] [Abstract][Full Text] [Related]
8. RING domain mutations uncouple TRIM5α restriction of HIV-1 from inhibition of reverse transcription and acceleration of uncoating.
Roa A; Hayashi F; Yang Y; Lienlaf M; Zhou J; Shi J; Watanabe S; Kigawa T; Yokoyama S; Aiken C; Diaz-Griffero F
J Virol; 2012 Feb; 86(3):1717-27. PubMed ID: 22114335
[TBL] [Abstract][Full Text] [Related]
9. Trim5alpha protein restricts both HIV-1 and murine leukemia virus.
Yap MW; Nisole S; Lynch C; Stoye JP
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10786-91. PubMed ID: 15249690
[TBL] [Abstract][Full Text] [Related]
10. Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction.
Stremlau M; Perron M; Welikala S; Sodroski J
J Virol; 2005 Mar; 79(5):3139-45. PubMed ID: 15709033
[TBL] [Abstract][Full Text] [Related]
11. Disruption of human TRIM5alpha antiviral activity by nonhuman primate orthologues.
Berthoux L; Sebastian S; Sayah DM; Luban J
J Virol; 2005 Jun; 79(12):7883-8. PubMed ID: 15919943
[TBL] [Abstract][Full Text] [Related]
12. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor.
Stremlau M; Perron M; Lee M; Li Y; Song B; Javanbakht H; Diaz-Griffero F; Anderson DJ; Sundquist WI; Sodroski J
Proc Natl Acad Sci U S A; 2006 Apr; 103(14):5514-9. PubMed ID: 16540544
[TBL] [Abstract][Full Text] [Related]
13. Interfering residues narrow the spectrum of MLV restriction by human TRIM5alpha.
Maillard PV; Reynard S; Serhan F; Turelli P; Trono D
PLoS Pathog; 2007 Dec; 3(12):e200. PubMed ID: 18166079
[TBL] [Abstract][Full Text] [Related]
14. Retroviral restriction factors Fv1 and TRIM5alpha act independently and can compete for incoming virus before reverse transcription.
Passerini LD; Keckesova Z; Towers GJ
J Virol; 2006 Mar; 80(5):2100-5. PubMed ID: 16474118
[TBL] [Abstract][Full Text] [Related]
15. A comparison of murine leukemia viruses that escape from human and rhesus macaque TRIM5αs.
Ohkura S; Stoye JP
J Virol; 2013 Jun; 87(11):6455-68. PubMed ID: 23536686
[TBL] [Abstract][Full Text] [Related]
16. SUMO-interacting motifs of human TRIM5α are important for antiviral activity.
Arriagada G; Muntean LN; Goff SP
PLoS Pathog; 2011 Apr; 7(4):e1002019. PubMed ID: 21490953
[TBL] [Abstract][Full Text] [Related]
17. Role of TRIM5α RING domain E3 ubiquitin ligase activity in capsid disassembly, reverse transcription blockade, and restriction of simian immunodeficiency virus.
Kim J; Tipper C; Sodroski J
J Virol; 2011 Aug; 85(16):8116-32. PubMed ID: 21680520
[TBL] [Abstract][Full Text] [Related]
18. Comparative requirements for the restriction of retrovirus infection by TRIM5alpha and TRIMCyp.
Diaz-Griffero F; Kar A; Lee M; Stremlau M; Poeschla E; Sodroski J
Virology; 2007 Dec; 369(2):400-10. PubMed ID: 17920096
[TBL] [Abstract][Full Text] [Related]
19. An invariant surface patch on the TRIM5alpha PRYSPRY domain is required for retroviral restriction but dispensable for capsid binding.
Sebastian S; Grütter C; Strambio de Castillia C; Pertel T; Olivari S; Grütter MG; Luban J
J Virol; 2009 Apr; 83(7):3365-73. PubMed ID: 19153241
[TBL] [Abstract][Full Text] [Related]
20. Virus-specific effects of TRIM5α(rh) RING domain functions on restriction of retroviruses.
Li X; Kim J; Song B; Finzi A; Pacheco B; Sodroski J
J Virol; 2013 Jul; 87(13):7234-45. PubMed ID: 23637418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
